News

Title Genuv’s Sungho Han Encourages Her Staff to Challenge the Status Quo 2021-11-10

Genuv’s Sungho Han Encourages Her Staff to Challenge the Status Quo

 

Genuv’s CEO Sungho Han, Ph.D., is a true Renaissance woman: a scientist, entrepreneur, patent law expert, conservatory-trained organist and visionary. Her approach to treating cancer and neurodegenerative diseases is powering Genuv to breakthroughs that promise new hope for patients with some of the most difficult-to-treat diseases. Dr. Han recently met with Gail Dutton, a writer for #Biospace, to discuss what drives her and her approach to drug development based on scientific imagination.

 

To view original article, please click here.

Prev Next-gen IL-2 GNUV204, selected by the Korean government for a development grant
Next Why Korea Is Now More Attractive To U.S. Biopharma